Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.875 USD | +3.35% | +3.83% | -6.87% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.87% | 414M | |
+2.16% | 42.75B | |
+47.75% | 41.61B | |
+12.03% | 41.34B | |
-12.36% | 26.59B | |
+8.11% | 25.49B | |
-23.50% | 18.12B | |
+30.25% | 12.24B | |
-1.90% | 11.76B | |
+8.10% | 11B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- H.C. Wainwright Initiates Coverage on Voyager Therapeutics With Buy Rating, $30 Price Target